Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts [NA]
Mayo Clinic conducted a study to evaluate molecular breast imaging as a screening tool for women with dense breasts. The trial is completed …
-
CLINICAL_TRIALS trial_result · 2013-12-25Clinical Trial Update: Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for ixabepilone with hydroxychloroquine in metastatic breast cancer; phases 1 and 2, terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy [Phase 2]
A Phase 2 trial of combining lapatinib with Caelyx in patients with advanced metastatic breast cancer after trastuzumab failure was terminat…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy [Phase 2]
Phase II trial of afatinib (BIBW 2992) for HER2-positive metastatic breast cancer after trastuzumab failure has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2013-12-23Clinical Trial Update: A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) [Phase 2]
A Phase II study of AZD2171 (cediranib) in stage IV breast cancer has completed, with results posted in December 2013.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating the combination of celecoxib and trastuzumab for metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Edotecarin in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Chemotherapy [Phase 2]
This clinical trial update reports on a Phase 2 study of edotecarin in women with locally advanced or metastatic breast cancer that has not …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer [Phase 3]
Phase 3 trial evaluating radiation therapy after surgery for women with early-stage breast cancer has completed. The document updates the co…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer [Phase 3]
A Phase 3 clinical trial comparing combination chemotherapy with or without epirubicin for women with stage I or stage II breast cancer has …
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer [Phase 3]
This Phase 3 trial evaluating adjuvant chemotherapy plus radiation therapy for women with early-stage breast cancer has completed. No result…
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating whether radiation therapy after surgery improves outcomes for women with early-stage breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer [Phase 3]
Phase 3 trial evaluating epirubicin and tamoxifen with or without docetaxel in postmenopausal women with breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer [Phase 2]
A Phase 2 clinical trial update comparing hyperbaric oxygen therapy to standard therapy for chronic arm lymphedema in cancer patients who ha…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating liposomal doxorubicin and gemcitabine in women with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial compares combination chemotherapy with mitoxantrone in older patients with advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
Clinical trial update exploring whether gene expression profiles can predict response to Paclitaxel in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Figitumumab Combined With Pegvisomant For Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the combination of figitumumab with pegvisomant for advanced solid tumors was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2013-12-11Clinical Trial Update: Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer [Phase 2]
A Phase 2 trial evaluated whether serum proteomic profiles can predict gemcitabine sensitivity in metastatic breast cancer; the study has co…
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer [Phase 1]
A Phase I trial evaluating the combination of dasatinib and capecitabine in women with advanced breast cancer has completed and posted resul…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing Epirubicin + Cyclophosphamide versus Epirubicin + Paclitaxel in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer [NA]
Clinical trial update on a psychosocial treatment aiming to improve survival in women with breast cancer; the Stanford study has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 trial of Nitrocamptothecin in locally recurrent or metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer [Phase 2]
Phase 2 study of famitinib malate in HER2-negative metastatic breast cancer has completed; this update reports the trial status.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer [Phase 2]
A Phase 2 study evaluated apatinib in non-triple-negative metastatic breast cancer and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities [NA]
A completed clinical trial assessing strategies to reduce underuse of early-stage breast cancer treatment in minority communities. Sponsored…